SPOCK1 and hepatocellular carcinoma: Among the proteins with increased EV abundance, we identified SPOCK1/testican-1, a proteoglycan increasingly accepted as oncogenic [32,33,34] that displayed over 10-fold elevation in the treatment-modulated EVs of both hepatoma cell lines.